NAD's architecture consists of: Nicotinamide base attached to a ribose sugar and phosphate group Adenine base connected to a ribose sugar and phosphate group Two phosphate groups that form the connecting bridge between these components Peptides, on the other hand, are made up of amino acids that link through peptide bonds
What the research firmly supports: BPC-157's gut healing, vascular, and neuroprotective mechanisms (strong preclinical evidence) Thymosin Alpha-1's immune modulating and T-cell restorative effects (strong preclinical + clinical evidence in viral disease) TB-500's cardiovascular repair and angiogenic properties (strong preclinical, early human data) What the research does not yet confirm: Randomised controlled trial data specifically in long COVID populations Optimal dosing, sequencing, and duration specifically for PASC Long-term safety data for extended post-viral use This doesn't mean these peptides don't work for long COVID
10.1210/endo.142.1.7894 245 QianF.HuoD
making it one of the most well-researched and versatile peptides in cellular repair and anti-aging
Metabolism of xenobiotics
Follow-up panels are recommended every 8 to 12 weeks